A carregar...

Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors. The first molecular targeted treatment

Chronic Myeloid Leukemia is the first malignant disorder with a specific genetic abnormality in the background. Known as a disease with an inexorable progression to acute leukemia for many years, its natural history has been dramatically improved by the use of tyrosine kinase inhibitors (TKI). They...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bumbea, H, Vladareanu, AM, Cisleanu, D, Barsan, L, Onisai, M, Voican, I
Formato: Artigo
Idioma:Inglês
Publicado em: Carol Davila University Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3019054/
https://ncbi.nlm.nih.gov/pubmed/20968202
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!